We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $133B
1-Year Est. Return 43.5%
This Fund
S&P 500
This Quarter Est. Return
+3.99%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$124B
AUM Growth
-$818M
Cap. Flow
-$3.27B
Cap. Flow %
-2.65%
Top 10 Hldgs %
32.71%
Holding
4,253
New
85
Increased
832
Reduced
2,978
Closed
67

Top Buys

Rank Stock Value
1
IWV icon
iShares Russell 3000 ETF
IWV
+$588M
2
CRH icon
CRH
CRH
+$47.1M
3
CVNA icon
Carvana
CVNA
+$34.4M
4
Q
Qnity Electronics Inc
Q
+$33.9M
5
PINS icon
Pinterest
PINS
+$27.9M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$326M
2
AAPL icon
Apple
AAPL
+$286M
3
MSFT icon
Microsoft
MSFT
+$251M
4
MRSH
Marsh
MRSH
+$174M
5
AMZN icon
Amazon
AMZN
+$94.5M

Sector Composition

Rank Sector Weight
1 Technology 32.19%
2 Financials 13.22%
3 Consumer Discretionary 10.75%
4 Healthcare 9.82%
5 Communication Services 9.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RBCAA icon
2251
Republic Bancorp
RBCAA
$1.91B
$807K ﹤0.01%
11,697
-2,149
-16% -$149K
DJCO icon
2252
Daily Journal
DJCO
$767M
$804K ﹤0.01%
1,649
-242
-13% -$108K
CTO
2253
CTO Realty Growth
CTO
$819M
$800K ﹤0.01%
43,471
-7,766
-15% -$133K
ABEV icon
2254
Ambev
ABEV
$43.5B
$799K ﹤0.01%
323,577
-2,874
-0.9% -$6.84K
FISI icon
2255
Financial Institutions
FISI
$825M
$797K ﹤0.01%
25,574
-4,478
-15% -$132K
METC icon
2256
Ramaco Resources Class A
METC
$692M
$797K ﹤0.01%
44,277
-120
-0.3% -$3.15K
ZBIO
2257
Zenas BioPharma
ZBIO
$1.98B
$797K ﹤0.01%
21,946
+732
+3% +$24.1K
TREE icon
2258
LendingTree
TREE
$444M
$789K ﹤0.01%
14,857
-1,936
-12% -$109K
SKYT
2259
DELISTED
SkyWater Technology
SKYT
$788K ﹤0.01%
43,411
-1,218
-3% -$21.2K
ELVN icon
2260
Enliven Therapeutics
ELVN
$4.24B
$778K ﹤0.01%
50,509
-9,651
-16% -$192K
NOK icon
2261
Nokia
NOK
$59B
$774K ﹤0.01%
119,656
+30,896
+35% +$192K
MPB icon
2262
Mid Penn Bancorp
MPB
$969M
$773K ﹤0.01%
24,928
-3,944
-14% -$117K
JBIO
2263
Jade Biosciences
JBIO
$1.48B
$772K ﹤0.01%
50,053
+7,269
+17% +$85.3K
SANA icon
2264
Sana Biotechnology
SANA
$1.1B
$771K ﹤0.01%
189,412
-6,294
-3% -$28.2K
CSV icon
2265
Carriage Services
CSV
$535M
$768K ﹤0.01%
18,145
-3,130
-15% -$136K
REP
2266
DELISTED
REPSOL YPF SA ADS(RP 1 CAP SH)
REP
$766K ﹤0.01%
41,006
+8,514
+26% +$159K
NWPX icon
2267
NWPX Infrastructure Inc
NWPX
$1.1B
$766K ﹤0.01%
12,251
-2,296
-16% -$132K
GSK icon
2268
GSK
GSK
$101B
$765K ﹤0.01%
15,608
-6,725
-30% -$314K
KALV
2269
DELISTED
KalVista Pharmaceuticals
KALV
$765K ﹤0.01%
47,391
-5,407
-10% -$71.6K
IIIV icon
2270
i3 Verticals
IIIV
$323M
$765K ﹤0.01%
30,375
-5,739
-16% -$162K
SPT icon
2271
Sprout Social
SPT
$579M
$765K ﹤0.01%
67,860
-23,722
-26% -$256K
GRDN
2272
Guardian Pharmacy Services
GRDN
$2.44B
$757K ﹤0.01%
25,151
+4,056
+19% +$115K
AMTB icon
2273
Amerant Bancorp
AMTB
$1.15B
$757K ﹤0.01%
38,781
-7,923
-17% -$147K
CYRX icon
2274
CryoPort
CYRX
$750M
$755K ﹤0.01%
78,693
-12,748
-14% -$120K
FLGT icon
2275
Fulgent Genetics
FLGT
$515M
$753K ﹤0.01%
28,663
-4,264
-13% -$111K

Similar funds

RhumbLine Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, RhumbLine Advisers held 4,253 positions worth $124B, down 0.66% from $125B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 3.6%. RhumbLine Advisers opened 85 new positions and exited 67, leaving the 4,253-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q4 2025 buy was Qnity Electronics Inc: 399,119 shares worth $32.6M.
  • RhumbLine Advisers added most to iShares Russell 3000 ETF in Q4 2025, an estimated $588M increase.
  • RhumbLine Advisers's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $326M.
  • RhumbLine Advisers fully exited Kellanova in Q4 2025, selling an estimated $52.6M.
  • RhumbLine Advisers's ten largest holdings make up 33% of its $124B portfolio in Q4 2025.
  • RhumbLine Advisers opened 85 new positions and closed 67 in Q4 2025.
  • RhumbLine Advisers's portfolio value fell 0.66% quarter-over-quarter to $124B.

Based on RhumbLine Advisers's 13F filing for Q4 2025, filed 13 Feb 2026.